How Alcohol, Caffeine, and Cannabis Affect Secondary Hypogonadism
Heavy alcohol use and long-term opioid treatment belong in a low-testosterone evaluation. Cannabis use also belongs in the history, but human studies do not show a consistent fall in testosterone. Coffee is not a treatment for secondary hypogonadism. The useful next step is to connect substance use, symptoms and properly timed hormone tests. [1-4]
Secondary hypogonadism means the brain and pituitary are not providing enough stimulation for normal testicular testosterone production. Testosterone is low while luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are low or inappropriately normal. The cause may involve a medicine, another health condition or a pituitary disorder. [1]
Which substances matter most?
| Substance | What the research means for a low-testosterone evaluation | Useful information to bring |
|---|---|---|
| Alcohol | Heavy or prolonged use can affect reproductive hormones and testicular function | Typical weekly intake, larger drinking occasions and any liver disease |
| Opioids | Long-term use can suppress the signals that support testosterone production | Medicine, dose, duration and recent changes |
| Cannabis | Hormone findings vary across human studies; use alone does not establish the cause of a low result | THC/CBD product, frequency, route and timing |
| Caffeine | Coffee trials do not establish a sustained testosterone benefit; timing can affect sleep | Total intake, serving sizes and time of the last dose |
The table is a guide to the history, not a ranking of individual products or a formula for predicting testosterone. [1-4,7,8]
How does alcohol affect testosterone?
Alcohol can act at several levels of the reproductive system. Heavy or chronic exposure can affect hypothalamic and pituitary signaling as well as the testes. Liver disease can change hormone metabolism and sex hormone-binding globulin (SHBG), which matters when interpreting total and free testosterone. Alcohol-related hypogonadism therefore does not always fit a purely central pattern. [5]
A 2023 meta-analysis included 40 studies involving 23,258 participants across its reproductive outcomes. The pooled hormone analyses found lower testosterone, LH and FSH with alcohol consumption. The studies used different populations and drinking categories, so their results cannot supply a personal percentage drop or a universal number of drinks that triggers hypogonadism. [2]
For an appointment, describe actual drinks and serving sizes rather than simply saying “social drinking.” If alcohol reduction is part of the plan, agree on the approach and follow-up with the clinician, especially after prolonged heavy use. A written record of intake and symptoms helps make the follow-up comparison useful. [6]
Does cannabis lower testosterone?
A cannabis history is relevant, but a low testosterone result should not automatically be attributed to THC. The American Society for Reproductive Medicine describes inconsistent findings for male reproductive hormones across studies. [3]
In a U.S. NHANES analysis of 1,577 men, testosterone did not differ significantly between men who had ever used marijuana and those who had never used it. More recent use was associated with higher testosterone. A separate NHANES analysis of 5,146 men also found a small positive association with regular use. These were observational analyses, not trials showing that cannabis treats low testosterone. [4,9]
Hormone concentrations and fertility are separate outcomes. A testosterone result does not reveal sperm count or motility. If conception is a goal, discuss cannabis within the fertility assessment rather than using testosterone alone to judge reproductive health. [3,10]
THC and CBD are different compounds, but switching to CBD is not an established treatment for secondary hypogonadism. Record the actual product and reason for use so the clinician can consider it alongside medicines, sleep and the test results.
Can coffee increase testosterone?
An eight-week randomized trial assigned 42 adults to caffeinated coffee, decaffeinated coffee or water. Although some hormone differences appeared at four weeks, there were no significant between-group differences in the measured outcomes at eight weeks. That result does not support prescribing coffee to produce a sustained testosterone increase. [7]
Sleep provides a more practical reason to review caffeine. In a randomized study, 400 mg taken at bedtime, three hours before bed or six hours before bed disrupted sleep compared with placebo. Dose and timing matter, and the amount in a “cup” varies considerably. [8]
Track whether late coffee, energy drinks or pre-workout supplements coincide with shorter sleep. Moving caffeine earlier or reducing the amount can be assessed by sleep quality and daytime function, without treating a stimulant as hormone therapy.
Why are opioids an important cause?
Long-term opioids can suppress the hypothalamic-pituitary-gonadal axis. The Endocrine Society identifies opioid use as a potentially reversible contributor to secondary hypogonadism. Sexual symptoms, fatigue and fertility concerns can prompt evaluation in someone receiving chronic treatment. [1,11]
The medication review should include the particular opioid, dose and duration. Any reduction or substitution needs to be coordinated with the prescriber, including the reason the opioid was started. Abrupt self-directed changes can cause withdrawal and disrupt pain treatment. The hormone plan and the pain or addiction-treatment plan need to work together. [11]
What tests clarify the diagnosis?
Diagnosis requires compatible symptoms and consistently low testosterone, usually confirmed with separate morning fasting measurements. LH and FSH distinguish the hormonal pattern. Free testosterone can help when total testosterone is borderline or SHBG is altered; further testing addresses the suspected cause. [12]
A repeat test is most useful when its conditions are documented. Bring the collection time, recent illness, sleep pattern, medicines and relevant substance changes. The clinician can then decide whether a follow-up result reflects a sustained change rather than a difference in sampling conditions. [12]
If fertility matters, discuss it before starting testosterone. Exogenous testosterone suppresses sperm production. Depending on the cause, a reproductive specialist may consider hCG, a selective estrogen receptor modulator or other fertility-directed treatment. A medicine that relies on pituitary signaling is not interchangeable with treatment for primary pituitary failure. [10]
When should the evaluation move faster?
New visual-field changes, a severe headache, unexpected nipple discharge or symptoms suggesting additional pituitary hormone deficiencies call for prompt assessment. These findings should not be explained away as a lifestyle effect. Pituitary imaging and additional hormone tests may be appropriate according to the presentation. [1]
How can you make the follow-up useful?
Before the visit, write down the symptoms you want to improve and when they began. Bring a complete medicine list and a realistic substance-use history. Agree on which change to make, when to reassess and which outcome matters, such as sexual symptoms, fertility, sleep or a repeat hormone result.
Changing several products every few days makes the result harder to interpret. A documented plan gives the clinician a clearer comparison and helps identify when another cause needs attention.
References
- Endocrine Society. Testosterone therapy in men with hypogonadism: clinical practice guideline. 2018.
- Nguyen-Thanh T, et al. Alcohol intake and male reproductive function: meta-analysis. 2023.
- American Society for Reproductive Medicine. Tobacco or marijuana use and infertility. 2024.
- Thistle JE, et al. Marijuana use and serum testosterone concentrations among U.S. males. 2017.
- The effects of alcohol on testosterone synthesis in men: a review. 2023.
- NIAAA. Should you cut down or quit?
- Wedick NM, et al. Caffeinated and decaffeinated coffee and endogenous sex hormones: randomized trial. 2012.
- Drake C, et al. Caffeine effects on sleep at zero, three or six hours before bedtime. 2013.
- THC use and testosterone among U.S. men: NHANES analysis. 2020.
- AUA/ASRM. Diagnosis and treatment of infertility in men: guideline amended 2024.
- Endocrine Society. Exogenous opioids and the human endocrine system: scientific statement. 2024.
- Society for Endocrinology and Association of Clinical Biochemistry and Laboratory Medicine. Biochemical confirmation of adult male hypogonadism. 2023.